GKOS – Glaukos Corporation

Glaukos Corporation

GKOS

$126.34

Name : Glaukos Corporation

Sector : Healthcare

Industry: Medical Devices

Mark. Cap: $7,420,442,112.00

EPSttm : -3.31

Glaukos Corporation

$126.34

3.59%

$4.38

GKOS — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

5.86

Margin Of Safety %

Put/Call OI Ratio

0.48

EPS Next Q Diff

0.05

EPS Last/This Y

2.77

EPS This/Next Y

0.99

Price

126.43

Target Price

154.5

Analyst Recom

Performance Q

22.48

Upside

-191.1%

Beta

0.76

Ticker: GKOS

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-05-11	GKOS	135.46	0.60	1.80	1661
2026-05-12	GKOS	136.4	0.61	4.88	1688
2026-05-13	GKOS	137.28	0.64	0.16	1730
2026-05-14	GKOS	142.14	0.63	0.25	1762
2026-05-15	GKOS	144	0.62	0.06	1776
2026-05-18	GKOS	142.13	0.37	0.36	627
2026-05-19	GKOS	139.85	0.39	0.30	678
2026-05-20	GKOS	143.72	0.40	0.36	680
2026-05-21	GKOS	139.12	0.40	9.00	691
2026-05-22	GKOS	120.13	0.46	0.90	738
2026-05-26	GKOS	114.89	0.86	1.76	1409
2026-05-27	GKOS	109.89	1.10	0.29	2079
2026-05-28	GKOS	106.57	1.09	0.03	2087
2026-05-29	GKOS	103.43	0.98	0.36	2199
2026-06-02	GKOS	110.69	0.60	0.01	2951
2026-06-03	GKOS	113.78	0.57	0.33	3068
2026-06-04	GKOS	121.7	0.55	0.13	3211
2026-06-05	GKOS	125.17	0.56	0.00	3210
2026-06-08	GKOS	122.07	0.48	0.67	3546
2026-06-09	GKOS	126.34	0.48	0.01	3545
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-05-11	GKOS	135.46	11.2	-	-0.51
2026-05-12	GKOS	136.39	11.2	-	-0.51
2026-05-13	GKOS	137.30	11.2	-	-0.51
2026-05-14	GKOS	142.12	11.2	-	-0.51
2026-05-15	GKOS	144.02	11.2	-	-0.51
2026-05-18	GKOS	142.13	11.2	-	-0.51
2026-05-19	GKOS	139.90	11.2	-	-0.51
2026-05-20	GKOS	143.79	11.2	-	-0.51
2026-05-21	GKOS	139.05	11.2	-	-0.51
2026-05-22	GKOS	120.23	11.2	-	-0.51
2026-05-26	GKOS	114.76	11.2	-	-0.51
2026-05-27	GKOS	109.87	11.2	-	-0.51
2026-05-28	GKOS	106.57	11.2	-	-0.51
2026-05-29	GKOS	103.38	11.2	-	-0.51
2026-06-01	GKOS	103.13	11.2	-	-0.51
2026-06-02	GKOS	112.99	11.2	-	-0.51
2026-06-03	GKOS	113.70	11.2	-	-0.51
2026-06-04	GKOS	121.67	11.2	-	-0.51
2026-06-05	GKOS	124.96	11.2	-	-0.51
2026-06-08	GKOS	122.09	11.2	-	-0.51
2026-06-09	GKOS	126.43	11.2	-	-0.51
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-05-11	GKOS	-12.68	2.73	5.76
2026-05-12	GKOS	-12.75	2.73	5.18
2026-05-13	GKOS	-12.75	2.73	5.18
2026-05-14	GKOS	-12.90	2.73	5.18
2026-05-15	GKOS	-12.90	2.73	5.18
2026-05-18	GKOS	-12.90	-1.86	5.18
2026-05-19	GKOS	-13.04	-1.86	5.18
2026-05-20	GKOS	-13.07	-1.86	5.18
2026-05-21	GKOS	-12.50	-1.86	5.15
2026-05-22	GKOS	-13.86	-1.86	5.15
2026-05-26	GKOS	-13.86	-0.72	5.15
2026-05-27	GKOS	-13.85	-0.72	5.15
2026-05-28	GKOS	-13.85	-0.72	5.86
2026-05-29	GKOS	-13.85	-0.72	5.86
2026-06-02	GKOS	-13.85	-1.28	5.86
2026-06-03	GKOS	-13.85	-1.28	5.86
2026-06-04	GKOS	-13.76	-1.28	5.86
2026-06-05	GKOS	-13.76	-1.28	5.86
2026-06-08	GKOS	-13.68	-1.68	5.86
2026-06-09	GKOS	-13.68	-1.68	5.86
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.18

Avg. EPS Est. Current Quarter

-0.21

Avg. EPS Est. Next Quarter

-0.13

Insider Transactions

-13.68

Institutional Transactions

-1.68

Beta

0.76

Average Sales Estimate Current Quarter

151

Average Sales Estimate Next Quarter

156

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

22.8

Max Drawdown 5-Year %

-59.6

Target Price

154.5

P/E

Forward P/E

285.01

PEG

P/S

13.46

P/B

10.99

P/Free Cash Flow

EPS

-3.29

Average EPS Est. Cur. Y

-0.51

EPS Next Y. (Est.)

0.48

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-34.34

Relative Volume

1.18

Return on Equity vs Sector %

-55.7

Return on Equity vs Industry %

-40

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ GKOS Healthcare

$126.34

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

12/20

Pullback

17/25

Volume

4/15

Valuation

12/20

TP/AR

4/10

Options

5/10

RSI

53.3

Range 1M

58.4%

Sup Dist

4.7%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

7/25

Growth

22/30

Estimates

4/20

Inst/Vol

6/15

Options

6/10

EPS Yr

42.9%

EPS NY

186.2%

52W%

73%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🔴 SELL -55.6% upside

Quality

6/30

Valuation

0/30

Growth

18/25

Stability

8/10

LT Trend

3/5

Upside

-55.6%

Quality

Glaukos Corporation

Sector: Healthcare

Industry: Medical Devices

Employees: 1094

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally. It offers iStent and iStent inject W micro-bypass stents designed to treat mild-to-moderate open-angle glaucoma through the restoration of the natural physiologic outflow pathways for aqueous humor. The company also provides iStent infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. In addition, the company develops iLink, a device used for the treatment of keratoconus without the removal of the epithelium; ILution, a platform of cream-based drug formulation applied to the outer surface of the eyelid for drop less transdermal delivery of pharmaceutically active compounds for the treatment of anterior segment eye disorders; and retinal XR platform to treat age-related macular degeneration, diabetic macular edema, retinal vein occlusion, and other posterior segment retinal diseases. It sells its products to ambulatory surgery centers, hospitals, and physician private practices through a direct sales organization, direct sales subsidiaries, and distributors. The company was formerly known as Transdx, Inc. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.

GKOS

Latest News

—

Caricamento notizie per GKOS…

stock quote shares GKOS – Glaukos Corporation Stock Price stock today

news today GKOS – Glaukos Corporation stock forecast ,stock prediction 2023 2024 2025

marketwatch GKOS – Glaukos Corporation yahoo finance google finance

stock history GKOS – Glaukos Corporation invest stock market

stock prices GKOS premarket after hours

ticker GKOS fair value insiders trading

GKOS – Glaukos Corporation

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: GKOS

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y